Susannah Streeter, Senior Investment and Markets Analyst, Hargreaves Lansdown
b'
\\nCellular Goods, a UK-based provider of premium consumer products based on biosynthetic cannabinoids, is pleased to announce that share dealings in its ordinary shares of \\xa30.001 each will commence on the main market of the London Stock Exchange from 8am today under the ticker symbol CBX.
\\n
\\n\\n
\\n\\n
\\n\\n
Susannah talks about today listing and thirteen times oversubscribed IPO.
\\n\\n
The Company has been admitted to the standard segment of the Official List following a significantly oversubscribed initial public offering that raised \\xa313 million before expenses for the Company.
\\n
\\nCommenting on Cellular Goods\' flotation, Alexis Abraham, Chief Executive Officer, said, " Cellular Goods\' debut on the London Stock Exchange is a major step in the Company\'s development and provides a strong foundation to execute our long-term growth strategy. We are delighted with the strong support from a wide range of institutional and retail investors to build premium consumer products based on biosynthetic cannabinoids under the Cellular Goods brand."\\xa0
\\n
\\nhttps://www.share-talk.com/susannah-streeter-senior-investment-markets-analyst-hargreaves-lansdown-interview/
\\n
\\n\\n
'
\\n
\\nCommenting on Cellular Goods\' flotation, Alexis Abraham, Chief Executive Officer, said, " Cellular Goods\' debut on the London Stock Exchange is a major step in the Company\'s development and provides a strong foundation to execute our long-term growth strategy. We are delighted with the strong support from a wide range of institutional and retail investors to build premium consumer products based on biosynthetic cannabinoids under the Cellular Goods brand."\\xa0
\\n
\\nhttps://www.share-talk.com/susannah-streeter-senior-investment-markets-analyst-hargreaves-lansdown-interview/
\\n
\\n\\n